Poteligeo
Generic name: mogamulizumab [ moe-GAM-ue-LIZ-ue-mab ]
Drug class: Miscellaneous antineoplastics
What is Poteligeo?
Poteligeo is used to treat mycosis fungoides or Sézary syndrome in adults.
Poteligeo is given after at least one other medication did not work or has stopped working.
Poteligeo may also be used for purposes not listed in this medication guide.
Poteligeo side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Some side effects may occur during the injection. Tell your caregiver if you feel dizzy, tired, itchy, hot or cold, or short of breath during the infusion.
Poteligeo may cause serious side effects. Call your doctor at once if you have:
-
painful mouth sores;
-
fever, chills, sore throat, cough;
Common side effects of Poteligeo may include:
-
diarrhea;
-
rash;
-
feeling tired;
-
bone pain, muscle pain; or
-
cold symptoms such as stuffy nose, sneezing, sore throat.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Warnings
Poteligeo can cause serious or life-threatening side effects.
Call your doctor at once if you have a skin rash, itching, blistering or peeling, painful mouth sores, fever, chills, flu-like symptoms, trouble breathing, diarrhea, or stomach pain.
Some side effects may occur during the injection. Tell your caregiver if you feel dizzy, tired, itchy, hot or cold, or short of breath.
Before taking this medicine
Tell your doctor if you have ever had:
-
a severe reaction after using Poteligeo;
-
liver disease, including hepatitis B;
-
lung problems;
-
an autoimmune disorder; or
-
a stem-cell transplant from a donor.
You may need to have a negative pregnancy test before starting this treatment.
Do not use Poteligeo if you are pregnant. It could harm the unborn baby. Use effective birth control while you are using this medicine and for at least 3 months after your last dose. Tell your doctor if you become pregnant.
It may not be safe to breast-feed while using this medicine. Ask your doctor about any risk.
How is Poteligeo given?
Poteligeo is given as an infusion into a vein. A healthcare provider will give you this injection.
Poteligeo must be given slowly, and the infusion can take at least 60 minutes to complete.
Poteligeo is given in a 28-day treatment cycle. You may need to use the medicine only during the first 1 to 3 weeks of each cycle. Your doctor will determine how long to treat you with this medicine.
You will need frequent medical tests to be sure this medicine is not causing harmful effects.
Related/similar drugs
prednisone, methotrexate, dexamethasone, Decadron, Deltasone
What happens if I miss a dose?
Call your doctor for instructions if you miss an appointment for your Poteligeo.
What happens if I overdose?
Since Poteligeo is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.
What should I avoid while receiving Poteligeo?
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
What other drugs will affect Poteligeo?
Other drugs may affect Poteligeo, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Poteligeo Biosimilars
Biosimilar and interchangeable products are biological products that are highly similar to and have no clinically meaningful differences from the reference product.
Reference products
These are biological products that have already been approved by the FDA, against which biosimilar products are compared. There is 1 for Poteligeo.
Poteligeo (mogamulizumab-kpkc) - Kyowa Kirin, Inc.
Formulation type | Strength |
---|---|
Single-Dose Vial | 20 mg/5 mL (4 mg/mL) |
Frequently asked questions
More about Poteligeo (mogamulizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2024 Cerner Multum, Inc. Version: 1.01.